Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LG00313112 in Advanced Solid Malignancies With TP53 Y220C Mutation
NCT07752875Phase 2Not yet recruiting
- Sponsor
- LG Chem
- Start
- Dec 2026
- Primary completion
- Oct 2032
01
Overview
A Phase 2 trial of LG00313112 in solid tumor, sponsored by LG Chem. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
LG00313112
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07752875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07752875.